{
    "Allocation": "Randomized",
    "CompleteTime": 0,
    "DesignModel": "Crossover Assignment",
    "DrugInformation": {
        "ArmGroupList": [
            {
                "ArmGroupDescription": "syp-1512: 1 tablet (once daily) PO, ",
                "ArmGroupLabel": "SYP-1512",
                "ArmGroupType": "Experimental",
                "InterventionDescription": [
                    {
                        "Dosage": "1 tablet",
                        "DrugName": "syp-1512",
                        "Duration": "(once daily)",
                        "HowToTake": "PO"
                    }
                ],
                "InterventionList": {
                    "ArmGroupInterventionName": [
                        "Drug: SYP-1512"
                    ]
                }
            },
            {
                "ArmGroupDescription": "revlimid cap: 1 capsule (once daily) po, ",
                "ArmGroupLabel": "Revlimid cap.",
                "ArmGroupType": "Active Comparator",
                "InterventionDescription": [
                    {
                        "Dosage": "1 capsule",
                        "DrugName": "revlimid cap",
                        "Duration": "(once daily)",
                        "HowToTake": "po"
                    }
                ],
                "InterventionList": {
                    "ArmGroupInterventionName": [
                        "Drug: Revlimid cap"
                    ]
                }
            }
        ]
    },
    "Enrollment": "42",
    "InterventionName": "",
    "Masking": "None (Open Label)",
    "NCTID": "NCT03208218",
    "Objective": "Crossover Study to Compare Pharmacokinetic Property of SYP-1512 Tab and Revlimid Cap in Healthy Male Volunteers",
    "OfficialTitle": "An Open-label, Randomized, Single Dose, Crossover Bioequivalent Study to Compare Pharmacokinetic Property of SYP-1512 Tab and Revlimid Cap, 25mg in Healthy Male Volunteers",
    "PopulationBox": {
        "Condition": "Healthy, Male",
        "Gender": "Male",
        "HealthyCondition": "Accepts Healthy Volunteers",
        "MaxAge": "50 Years",
        "MinAge": "20 Years",
        "Participant": "42"
    },
    "PopulationRatio": "",
    "Title": "Crossover Study to Compare Pharmacokinetic Property of SYP-1512 Tab and Revlimid Cap in Healthy Male Volunteers",
    "WashoutPeriod": ""
}